Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

Citizens JMP analyst Jonathan Wolleben lowered the firm’s price target on Aura Biosciences (AURA) to $19 from $21 and keeps an Outperform ...

(the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly TBM-001 ...

Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares despite showing ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

The following is a summary of "Early prediction of progression-free survival of patients with locally advanced nasopharyngeal ...

From: Susan Gallien ...

The complexity of the TME in vivo limits the conclusions that can be drawn from in vivo models. Optimizing cell culture ...

Ruan Xiangyan, a pioneer of ovarian tissue cryopreservation and transplantation, speaks during a meeting of deputies from the ...

Three years after her initial breast cancer diagnosis, Wu faced recurrence last year, at which point she was already battling stage III cancer with metastasis to her lymph nodes. Recently, she took to ...